Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000643315 | SCV000765002 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-08-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002343293 | SCV002619721 | uncertain significance | Cardiovascular phenotype | 2018-10-31 | criteria provided, single submitter | clinical testing | The p.D12541H variant (also known as c.37621G>C), located in coding exon 137 of the TTN gene, results from a G to C substitution at nucleotide position 37621. The aspartic acid at codon 12541 is replaced by histidine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002509488 | SCV002819879 | uncertain significance | not specified | 2022-12-04 | criteria provided, single submitter | clinical testing |